Hikari Power Ltd - Q2 2017 holdings

$741 Million is the total value of Hikari Power Ltd's 94 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 159.1% .

 Value Shares↓ Weighting
UTX BuyUNITED TECHNOLOGIES CORP$18,768,000
+47.8%
153,700
+35.8%
2.53%
+40.0%
DHR BuyDANAHER CORP$18,211,000
+1.2%
215,800
+2.6%
2.46%
-4.1%
PSX BuyPHILLIPS 66$17,836,000
+10.2%
215,700
+5.6%
2.40%
+4.4%
WAB BuyWABTEC CORPORATION$15,665,000
+747.2%
171,200
+622.4%
2.11%
+703.4%
POT BuyPOTASH CORP SASK INC$13,630,000
+9.5%
836,200
+14.8%
1.84%
+3.8%
NOV BuyNATIONAL OILWELL VARCO INC$9,665,000
-9.1%
293,400
+10.6%
1.30%
-13.9%
WAT NewWATERS CORPORATION$9,523,00051,800
+100.0%
1.28%
GILD BuyGILEAD SCIENCES INC$9,154,000
+160.7%
129,330
+150.2%
1.24%
+147.0%
FTV BuyFORTIVE CORP$8,977,000
+41.7%
141,700
+34.7%
1.21%
+34.4%
AMGN BuyAMGEN INC.$7,354,000
+8.0%
42,700
+2.9%
0.99%
+2.4%
BIIB BuyBIOGEN INC$6,165,000
+2.5%
22,720
+3.3%
0.83%
-2.9%
DOFSQ BuyDIAMOND OFFSHORE DRILLING INC$6,148,000
+234.9%
567,700
+416.6%
0.83%
+217.6%
ESRX NewEXPRESS SCRIPTS HOLDING INC$4,894,00076,660
+100.0%
0.66%
VOO NewVANGUARD S&P 500 ETFetf$2,998,00013,500
+100.0%
0.40%
SGYPQ BuySYNERGY PHARMACEUTICALS INC$2,225,000
+218.3%
500,000
+233.3%
0.30%
+203.0%
BDSI BuyBIODELIVERY SCIENCES INTERNATIONAL INC$1,684,000
+234.8%
601,285
+127.2%
0.23%
+215.3%
JKHY NewJACK HENRY & ASSOCIATES INC$1,423,00013,700
+100.0%
0.19%
AMAG BuyAMAG PHARMACEUTICALS INC$1,288,000
+42.8%
70,000
+75.0%
0.17%
+35.9%
ASHR NewDEUTSCHE X - TRACKERS HARVEST CSI 300 CHINA A - SHARES FUNDetf$968,00035,500
+100.0%
0.13%
OPK BuyOPKO HEALTH INC$917,000
+28.3%
139,405
+55.9%
0.12%
+21.6%
DVAX BuyDYNAVAX TECHNOLOGIES CORPORATION$808,000
+171.1%
83,755
+67.5%
0.11%
+159.5%
ACOR BuyACORDA THERAPEUTICS INC$703,000
+234.8%
35,663
+256.6%
0.10%
+216.7%
AIMT NewAIMMUNE THERAPEUTICS INC$617,00030,000
+100.0%
0.08%
ALXN NewALEXION PHARMACEUTICALS INC$608,0005,000
+100.0%
0.08%
ANIP BuyANI PHARMACEUTICALS INC$568,000
+129.0%
12,130
+142.6%
0.08%
+120.0%
SYNT BuySYNTEL INC$530,000
+59.6%
31,270
+58.7%
0.07%
+51.1%
ALDX BuyALDEYRA THERAPEUTICS INC$507,000
+169.7%
107,858
+186.4%
0.07%
+151.9%
EIGR BuyEIGER BIOPHARMACEUTICALS INC$482,000
+308.5%
60,992
+491.0%
0.06%
+282.4%
VWO NewVANGUARD FTSE EMERGING MARKETS ETFetf$449,00011,000
+100.0%
0.06%
L NewLOEWS CORPORATION$454,0009,700
+100.0%
0.06%
OCRX BuyOCERA THERAPEUTICS INC$437,000
+33.2%
376,596
+50.6%
0.06%
+25.5%
MRTX NewMIRATI THERAPEUTICS INC$365,000100,000
+100.0%
0.05%
ECL NewECOLAB INC$279,0002,100
+100.0%
0.04%
CYOU NewCHANGYOU.COM LTD$284,0007,340
+100.0%
0.04%
AKTX NewAKARI THERAPEUTICS PLC$277,00060,012
+100.0%
0.04%
TPX NewTEMPUR SEALY INTERNATIONAL INC$232,0004,350
+100.0%
0.03%
BBY NewBEST BUY CO INC$233,0004,060
+100.0%
0.03%
USNA NewUSANA HEALTH SCIENCES INC$221,0003,440
+100.0%
0.03%
TUP NewTUPPERWARE BRANDS CORPORATION$220,0003,130
+100.0%
0.03%
LB NewL BRANDS INC$219,0004,070
+100.0%
0.03%
NVR NewNVR INC$217,00090
+100.0%
0.03%
CSGS NewCSG SYSTEMS INTERNATIONAL INC$217,0005,350
+100.0%
0.03%
CI NewCIGNA CORPORATION$216,0001,290
+100.0%
0.03%
RHI NewROBERT HALF INTERNATIONAL INC$204,0004,260
+100.0%
0.03%
SIMO NewSILICON MOTION TECHNOLOGY CORPORATION$204,0004,230
+100.0%
0.03%
RTN NewRAYTHEON COMPANY$208,0001,290
+100.0%
0.03%
NTES NewNETEASE INC$210,000700
+100.0%
0.03%
SHOO NewSTEVEN MADDEN LTD$211,0005,290
+100.0%
0.03%
UBNT NewUBIQUITI NETWORKS INC$205,0003,950
+100.0%
0.03%
CA NewCA, INC.$211,0006,130
+100.0%
0.03%
VRSN NewVERISIGN INC$207,0002,230
+100.0%
0.03%
WNC NewWABASH NATIONAL CORPORATION$209,0009,510
+100.0%
0.03%
AOBC NewAMERICAN OUTDOOR BRANDS CORPORATION$210,0009,480
+100.0%
0.03%
RAI NewREYNOLDS AMERICAN INC$200,0003,080
+100.0%
0.03%
BIDU NewBAIDU INC$200,0001,120
+100.0%
0.03%
TOUR NewTUNIU CORPORATION$189,00023,520
+100.0%
0.02%
VIPS NewVIPSHOP HOLDINGS LTD$152,00014,450
+100.0%
0.02%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Yasumitsu Shigeta #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CARDINAL HEALTH39Q3 202340.7%
WELLS FARGO & CO NEW39Q3 202317.8%
JOHNSON & JOHNSON39Q3 202324.8%
VISA INC CLASS A39Q3 20234.1%
NOVO-NORDISK A S39Q3 20234.2%
EXXON MOBIL CORPORATION39Q3 20233.9%
NESTLE SA39Q3 20233.6%
COCA COLA CO39Q3 20236.4%
INTUITIVE SURGICAL INC39Q3 20232.2%
BECTON DICKINSON & CO39Q3 20232.8%

View Hikari Power Ltd's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-08
13F-HR2024-01-31
13F-HR2023-10-26
13F-HR2023-07-26
13F-HR2023-04-26
13F-HR2023-01-25
13F-HR2022-11-01
13F-HR/A2022-07-22
13F-HR2022-07-06
13F-HR2022-04-13

View Hikari Power Ltd's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (741483000.0 != 741485000.0)

Export Hikari Power Ltd's holdings